Data supporting the article "The role of cytokine licensing in shaping the therapeutic potential of Wharton's jelly MSCs: metabolic shift towards immunomodulation at the expense of differentiation"

Data set includes the following files:

1. Figures described in the article:

   Figure 1. Changes in the transcriptomic profile of WJ-MSCs (N=7) following the cytokine licensing:
   A – Principal component analysis (PCA) of transcriptome data from unprimed (light blue) and primed (dark blue) samples.
   B – Volcano plot depicting pathway-level enrichment analysis across various biological databases, including Hallmark, KEGG, REACTOME, Gene Ontology, and WikiPathways. Each point represents a distinct pathway, with the x-axis showing the normalized enrichment scores and the y-axis displaying the -log10 adjusted p-value.
   C – Enrichment plots for two hallmark gene sets significantly upregulated in primed samples: Interferon Gamma Response and TNFA signalling via NFKB pathways. Green curves represent the enrichment score (ES), while black bars indicate the position of genes within the ranked list.
   
   Figure 2. Distribution of up- and downregulated genes (fold changes, FC) referred to cell differentiation following cytokine priming based on analysis of the Gene ontology (GO) terms. The following GO terms are presented: GO:0002062 Chondrocyte differentiation, GO:0045445 Myoblast differentiation, GO:0035914 Skeletal muscle cell differentiation, GO:0051145 Smooth muscle cell differentiation, GO:0045444 Fat cell differentiation, GO:0001649 Osteoblast differentiation, GO:0030182 Neuron differentiation, GO:0030154 Cell differentiation.
   
   Figure 3. The expression of osteogenic and adipogenic genes of unprimed and cytokine licensed WJ-MSCs (N=4, in duplicates) following the 7 days of the differentiation induction. Data is presented as Mean ± SD relative expression of induced cells to control cells (not subjected to differentiation induction). Note: Ns – non-significant; * - p<0.05; ** - p<0.01.
   
   Figure 4. The content of secreted growth factors in the conditioned medium of WJ-MSCs (N=4, in duplicates). Data is presented as Mean ± SD. Note: * - p<0.05.
   
   Figure 5. The oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of the unprimed and cytokine licensed WJ-MSCs (N=6, in triplicates) assessed using Seahorse assay. Note: Ns – non-significant; * - p<0.05; ** - p<0.01; *** - p<0.001.

   Figure 6. Metabolomic and lipidomic profile of WJ-MSCs following the cytokine licensing (N=4, in duplicates):
   A - Principal component analysis (PCA) of metabolomic data from unprimed (light blue) and primed (dark blue) WJ-MSCs samples.
   B – Volcano plot depicting clear separation of the main metabolite classes in WJ-MSCs induced by the cytokine priming. Each point represents a distinct most enriched metabolite within the pathway. Abbreviations: Tricarboxylic acid cycle metabolites (TCA), triglycerides (TG), free fatty acids (FAs), lysophosphatidylcholines (LPC), lysophosphatidylethanolamines (LPE), cholesterol esters (CE), and amino acids (AAs).
   C – The changes in selected metabolite families in WJ-MSCs following the cytokine priming. Note: Ns – non-significant; * - p<0.05; ** - p<0.01.

   D – Dot plot depicting log2 fold changes in metabolite levels between cytokine-primed WJ-MSCs and unprimed controls. Each dot represents a metabolite, with its position indicating the magnitude of fold change (log2) and its color/size denoting statistical significance.

2. Supplementary materials: Table 1. The list of the most up- or down-regulated genes (log2fold >1, p<0.001), detected in RNA-seq results. Figure 1S. Changes in expression of genes of interest after short-term cytokine licensing. Note: ** -p<0.01; *** - p<0.001. Figure 2S. The expression of osteogenic and adipogenic genes of unprimed and cytokine licensed WJ-MSCs (N=4 in duplicates) with and without IDO inhibition by 1-methyl-DL-tryptophan (1-MT, 1 mM) following the 7 days of the differentiation induction. Data is presented as Mean ± SD relative expression of induced cells to control cells (not subjected to differentiation induction) Ns – non-significant; * - p<0.05; ** - p<0.01.
3. RNA sequencing (initial data)
4. Metabolomic analysis (initial data)
5. List of normalized enrichment scores depicting pathway-level analysis across various biological databases, including Hallmark, KEGG, REACTOME, Gene Ontology, and WikiPathways (*file GO_terms)